Abstract
Purpose:
The purpose of this study was to discuss the propensity of aerosol and droplet generation during vitreoretinal surgery using high speed imaging amidst the coronavirus disease 2019 (COVID-19) pandemic.
Methods:
In an experimental set up, various steps of vitreoretinal surgery were performed on enucleated goat eyes. The main outcome measures were visualization, quantification of size, and calculation of aerosol spread.
Results:
During intravitreal injection, insertion of cannulas, lensectomy, and vitrectomy with both 23 and 25-gauge instruments, with either valved or nonvalved cannulas, aerosols were not visualized which was confirmed on imaging. Although there was no aerosol generation during active fluid air exchange (FAE), there was bubbling and aerosol generation at the exit port of the handle during passive FAE. Under higher air pressure, with reused valved and fresh nonvalved cannulas, aerosol generation showed a trajectory 0.4 to 0.67 m with droplet size of 200 microns. Whereas removing cannulas or suturing under active air infusion (35 mm Hg and above) aerosols were noted.
Conclusions:
Based on the above experiments, we can formulate guidelines for safe vitrectomy during COVID-19. Some recommendations include the use of valved cannulas, avoiding passive FAE or to direct the exit port away from the surgeon and assistant, and to maintain the air pressure less than or equal to 30 mm Hg.
Translational Relevance:
In the setting of the COVID-19 pandemic, the risk from virus laden aerosols, as determined using an experimental setup, appears to be low for commonly performed vitreoretinal surgical procedures.
Three freshly enucleated goat eyes were used for the experiments, one each for the 23-guage and 25-guage procedures, whereas the third was used for the rest. All experiments were performed by a single vitreoretinal surgeon to reduce the variability in technique. Aerosol generation for each of the experiments had to be captured within 1 second at 5000 fps, and we repeated the procedures (ranging from 1–5 times) until we were able to capture the same. If aerosols were not imaged even after the fifth attempt, we concluded that there were no aerosols generated from that particular procedure. Each attempt at imaging was done from different angles so as to not miss imaging any of the generated aerosols. The pathway of droplet generation is bubble formation and its breakup. Continuous bubble expansion results in thinning of the liquid film (the bubble surface). Consequently, this layer shears off and the bubble bursts, thereby resulting in liquid ligaments. These ligaments further elongate and atomize to form smaller droplets or aerosols.
While performing intravitreal injections, insertion of cannulas (both 23- and 25-gauge and valved and nonvalved), lensectomy and vitrectomy with both 23- and 25-gauge instruments, with either valved or nonvalved cannulas and instrument exchange, we did not find any aerosol generation, which was confirmed on high speed imaging. During the insertion and removal of a 20-guage MVR blade, there was fluid flow but no aerosols. Although there was no aerosol generation during active FAE while performing passive FAE using a Charles flute needle and handle, there was bubbling and aerosol generation at the exit port of the handle under higher air pressures.
Those procedures in which aerosols were visualized are further elucidated below:
- 23-guage valved under 60 mm Hg air pressure - During this procedure, droplets of sizes ranging between approximately 60 and 800 µm were observed. Ejection velocity for smaller droplets was approximately 0.1 to 1.0 m/sec whereas bigger droplets (approximately 800 µm) exhibited a velocity of approximately 0.009 m/sec. The trajectory of the smaller droplets were straight (Fig. 3A) whereas for bigger droplets (approximately 800 µm) it was parabolic (Fig. 3B).
- 25-guage valved under 60 mm Hg air pressure - During this procedure, droplets of sizes ranging between approximately 150 and 300 µm with an ejection velocity of approximately 0.35 to 1.0 m/sec were observed due to bubble break-up, as shown in Figure 4.
- 25-guage valved under 35 mm Hg air pressure - During this procedure, droplets of sizes ranging between approximately 100 and 300 µm with an ejection velocity of approximately 0.4 to 3.5 m/sec were observed post bubble rupture (Fig. 5).
- 25-guage valved cannula removal and suturing under 35 mm Hg air pressure - Droplets sized approximately 100 µm with an ejection velocity of approximately 0.45 to 2.2 m/sec were generated via bubble breakup and ligament formation.
- Passive FAE with 35 mm Hg air pressure - Droplets sized approximately 300 to 800 µm were seen with an ejection velocity approximately 0.45 to 2.2 m/sec for smaller droplets and approximately 0.04 m/sec for bigger droplets (approximately 800 µm). These droplets were generated via bubble breakup and ligameet formation, as shown in Figure 6.
We saw significant aerosols, even with valved cannulas, irrespective of the gauge when the air pressure was 35 mm Hg or more. We then gradually reduced the pressure and noted that aerosols were not observed in any of the procedures when the air pressure was 30 mm Hg or less.
Ophthalmologists are likely to be at high risk of contracting COVID-19 due to aerosol generating procedures, both in the outpatient department and operating theatre. For the protection of eye surgeons during this pandemic, it is not only essential to recognize which procedures are aerosolizing, but also to determine their risk potential. Whereas coughing and sneezing results in larger droplets, the risk of inhaling potentially smaller SARS-CoV-2 infected aerosols should not be neglected when performing procedures. With anecdotal reports on viral load in the tears and conjunctiva, the consequences could be serious. Hence, an effective risk assessment of common steps during vitreoretinal surgery can help understand the risk of transmission to health care professionals.
17 Because droplets in the size range of 0.05 to 500 µm contribute to the spread of airborne diseases, it was important to ascertain the size and spread of aerosols during surgical maneuvers.
23
A high-resolution camera and high-speed imaging can capture particle sizes as small as 50 µm. Although imaging techniques like schlieren and shadowgraphy offer better resolution and lower detection limit, high speed imaging is simpler to implement and efficient when done at high frame rate (5000 fps) and using a fast shutter speed (0.2 millisecond).
24 Hence, both the resolving power of the imaging system and the acquisition rate are critical to ensure better droplet detection. With custom camera settings and adequate illuminating light source, a resolution of approximately 0.05 mm/pixel was possible for this study. In the aerosol generating procedures of our experiments, the droplets size was predominantly in the range of approximately 100 to 200 µm. Based on the initial velocity, their horizontal displacement was evaluated (and the range of displacement was found to be approximately 0.4–1.8 m). Another important determinant of how far the aerosols can travel is the trajectory. For smaller droplets, it was straight and parabolic for the bigger droplets approximately 800 µm. This implies that the bigger droplets settle down faster as compared to the smaller ones.
Using high speed imaging and a simulated vitreoretinal surgery set up, we sought to determine if aerosols are generated. Our methodology differs from previous similar studies.
12,25,26 We used enucleated animal eyes to more accurately simulate the biomechanics of human tissue and high-speed imaging to detect the smallest of aerosols during vitrectomy. The cannulas were placed 3 to 4 mm from the limbus to ensure that there is no influence on aerosol generation. Disruption of the surface tension of the air–fluid interface at the sclera or ports by mechanical or pressurized airflow gives rise to aerosols. A lensectomy was done to allow better visibility of the vitreous cavity as we could not use a visualization system for the experimental set up. During insertion of different types and gauges of cannulas or while doing vitrectomy or lensectomy, there were no aerosols noted. Possible reasons are that the high-frequency back-and-forth motion of the guillotine blade does not dispense enough energy or the direction or diffusion of energy release may not disrupt the interface sufficiently, or any droplets or aerosols formed by the blade at the interface are immediately aspirated by the vacuum or prevented from escaping to the surface, as noted by the absence of aerosols when valved cannulas were used, as also elucidated by Liyanage et al.
26
Because vitrectomy is done in a “closed chamber,” it is also less likely to generate aerosols. Unless there is an air–fluid interface, such as during FAE, aerosol production is negligible. We did not notice aerosols at the beginning of FAE or after completion of the process due to the absence of an air–fluid interface as long as the air pressure was less than or equal to 30 mm Hg. However, when the air pressure exceeded 30 mm Hg, we noticed significant aerosols, even with valved cannulas, irrespective of the gauge. This risk is higher for passive FAE as no aerosol was noted during active FAE using the suction of the vitrector. We also saw higher aerosol generation in reused and nonvalved cannulas. Another important point to keep in mind is that once the vitrectomy is complete, the source of the aerosols could be either contaminated surface hemorrhage and/or sterile balanced salt solution.
Keeping the above in consideration we recommend the following:
- • the use of new and valved cannulas
- • to avoid passive FAE or to direct the exit port of the handle away from the surgeon and assistant
- • to maintain air pressure at less than or equal to 30 mm Hg
- • to stop active pressurized air infusion or clamp the air infusion tubing prior to removal of cannulas and suturing.
Our aim was to assess the risk of transmission of SARS-CoV-2 virus from infected patients to the operating surgeon during surgery. There are no reports so far of the coronavirus being detected in the aqueous or vitreous humor. However, with evidence of the virus being isolated from the ocular surface, it could pose a threat to vitreoretinal surgeons.
9 With the routine pre-operative povidone iodine preparation prior to any intraocular surgery and the virucidal activity of iodine, the presence of virus in the conjunctival sac is likely to be low.
27,28 Furthermore, the risk of disease transmission during surgery can be minimized if additional precautions, such as masks for the patients, use of betadine prior to the surgery, and the use of a protective shield between the surgical area and personnel when feasible.
29–31 Recent evidence suggests that medical masks and N95 respirators offer similar protection against COVID-19 in healthcare workers during non-aerosol-generating care.
32–33 Although there has been no trial so far on specifically preventing COVID-19, wearing N95 respirators can prevent 73 more clinical respiratory infections per 1000 healthcare workers compared to surgical masks.
34
Aerosols emitted during breathing and typical speech average only 1 µm in diameter but, despite their small size, they are large enough to carry a variety of respiratory pathogens.
35 We were able to demonstrate the generation of aerosols with pathogen carrying potential, and the speed and distance travelled by them during vitrectomy procedures. It not only helps us to formulate guidelines on safe practice during this pandemic, but also guide us on remedial measures during the surgical procedure. Given the limitations of the available research and knowledge surrounding this topic and based on the findings of this study, we recommend vitreoretinal surgeons to be cautious. As the consequences of being infected with SARS-CoV-2 are significant, a careful balance between the potential harms of the procedure and adopting enhanced personal protective protocols is reasonable. The quantification of the aerosol generation, direction, and speed helps to take practical decisions in surgical techniques during the pandemic. Further research is needed to clarify the degree to which various personal protective equipment reduces the risk associated with each procedure during the COVID-19 pandemic.
Disclosure: C. Jayadev, None; T. Mochi Basavaraj, None; K. Pandey, None; R. Pinto, None; S.P. Pandey, None; S. Basu, None; A.S. Roy, None; R. Shetty, None